Speedwinds picks Sephren
This article was originally published in The Tan Sheet
Executive SummaryPortland, Ore.-based Speedwinds Nutrition purchases the "dominant women's hair loss product on the market today" from Meliorra Nutraceuticals for an undisclosed amount. Sephren, a two-part system comprising a foam-based topical solution (containing cocamidopropyl betaine, a medium strength surfactant with antiseptic properties, propylene glycol, a moisturizer, among other ingredients) along with a supplement tablet, which contains B vitamins and other nutrients, to fight hair loss in women, Speedwinds says Sept. 12
You may also be interested in...
While the global health threat from the now officially named SARS-CoV-2 coronavirus has grown since the start of the quarterly earnings season in early February, even many of the companies reporting more recently do not appear overly concerned about potential business impact at this stage.
Sanofi seeks to delay decision clearing path for Mylan's Lantus biosimilar; says it should be able to get rehearing based on Federal Circuit's ruling that PTAB judges were not constitutionally appointed.
First Circuit reverses dismissal of direct purchasers' suit alleging improper listing of patent on device drive mechanism delayed competition; district court to decide if this constitutes antitrust violation.